Email from Leo
Permission to post.
I actually spend a
Email from Leo
Permission to post.
I actually spend a lot of my time with answering emails. It s impossible for me to answer all the emails and calls I get. Thats why we issue press releases more often than other companies. I will even try to increase my communication with shareholders.
See my responses in Red
Can you explain why phase 3 for Brilacidin has taken so long to get approval from the FDA? Is there some problem? We needed to analyze each sample of each patient for various tests. This was something we didn't expect would be needed considering the very positive results of the trial. This has been completed now and a meeting has been scheduled with the FDA. (this was announced in our update)
With ASCO, two years later, will there be significant new information. Why has the results of phase 1 not been impressive enough to be more that just a poster, among the hundreds of others. Absolutely incorrect. The results are very impressive to say the least. Please note our shareholder update. Shareholders may not understand but concerning an ongoing Phase 1 trial, clinical efficacy may not be reported in a poster presentation. There are limits what may be presented. Shortly we will advancing kevetrin very rapidly. I will address this in an upcoming press release.
What about the article on Kevetrin that was asked of the company to write, how is that coming along? This is for a peer reviewed journal. We believe we are near to closing out this study and releasing all clinical results makes for a more powerful paper.
Has anything come out of the ECCMID for CTIX? Of course. Many companies are very interested with what we are doing and it was an opportunity to update them. We need to start a phase 3 to take it further.
Is there any of 'the best is yet to come' available for release soon, two year after ASCO 2013 the stock is now trading about 40 cents over what it was going into ASCO in 2013.
Makes no sense to me, but I am confident this will pass as we continue executing on our plan. Unfortunately we had delays but now everything is coming together. This should be evident over the next weeks. We have some of the leading compounds in the world.
Everything I state to shareholders is public information and may be shared. Best wishes, LEO
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...
Continue Reading
RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...
Continue Reading
A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...
Continue Reading
Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...
Continue Reading
A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...
Continue Reading
Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...
Continue Reading
Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...
Continue Reading
A pair of trophies is nice; the underlying work matters more. MassMedia picked up two honors at the 2026 PRSA Las Vegas Valley Chapter Pinnacle Awards, presented October 28 at Siena Golf Club. One was a Pinnacle Award in Community Relations for its Safe Teen Driving work with Sam & Ash Injury Law. The other was an Award of Excellence in Reputation and Brand Management for...
Continue Reading
Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...
Continue Reading
Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...
Continue Reading
Top 5 Most Recently Viewed Articles
Inbank's Successful Subordinated Bond Subscription Recently, Inbank wrapped up its public offering of subordinated bonds, marking a significant moment in the company's financial journey. The event attracted considerable attention, with an impressive 935 investors participating, ultimately subscribing to bonds worth a total of 21.6 million euros. This enthusiasm resulted...
Continue Reading
Class Action Filed Against Starbucks Corporation The Gross Law Firm is reaching out to investors of Starbucks Corporation (NASDAQ: SBUX) following significant financial announcements and issues raised concerning the company's recent performance. The Purpose Behind the Class Action This class action aims to provide shareholders who purchased SBUX stocks during the recently...
Continue Reading
Revolutionizing Franchising Education The University of Tennessee's Haslam College of Business is proud to offer its franchising certification program without any fees, thanks to the generous support of successful entrepreneur Shelly Sun Berkowitz. As the founder and executive chairwoman of BrightStar Group Holdings Inc., Berkowitz brings invaluable experience to the...
Continue Reading
Ultra Maritime Opens New Innovative Facility Today marks an exciting new chapter for Ultra Maritime as it inaugurates its latest integrated design and manufacturing center. This state-of-the-art facility is dedicated to supporting the evolving needs of global allied navies, particularly in anti-submarine warfare (ASW). The center, located in Greenford, UK, offers a modern...
Continue Reading
Robin Hood Introduces a New Fundraising Venture In an exciting move that demonstrates their ongoing commitment to combating poverty, Robin Hood, New York's most extensive poverty-fighting organization, has launched a unique fundraising initiative titled 'The Robin Hood Pick-A-Ticker: A Fundraiser for Robin Hood (and your Favorite Charity!).' This initiative is made...
Continue Reading